Loading organizations...
§ Venture Capital · Taipei, T'ai-pei, Taiwan
A corporation in the life science venture sector. No public information is available on its specific activities.
Boston Life Science Venture is a venture capital firm specializing in seed to late-stage investments within the life science sector. Based in Taipei, Taiwan, the firm deploys capital across various growth phases, including expansion and growth stages, to foster innovation in biotech and related fields. Its investment strategy is focused on identifying and nurturing companies poised for significant advancement in the life sciences.
The firm was established in 2003. While specific details regarding its individual founders and the precise insight that led to its inception are not publicly detailed, its establishment coincided with growing interest in biotechnology ventures. The company's origin reflects a strategic move to capitalize on and contribute to the burgeoning life science ecosystem, particularly within the Asian market.
Boston Life Science Venture primarily serves early to growth-stage life science companies seeking capital and strategic partnership for development. The firm’s overarching vision is to drive progress in the life sciences by providing essential funding and support, thereby accelerating the development of novel therapies, diagnostics, and technologies. It aims to be a foundational partner for entrepreneurs shaping the future of health.
Boston Life Science Venture Corporation has 1 tracked investment across 1 company. The latest tracked deal is $45.0M Series D in Nereus Pharmaceuticals in August 2007.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 9, 2007 | Nereus Pharmaceuticals | $45.0M Series D | Bankinvest Biomedical Venture | Advent International, Alta Partners, Astellas Venture Management, Eminent II Venture Capital, Forward Ventures, GIMV, HBM Healthcare Investments, Interwest Partners, Pacific Venture Group, Roche, Taiwan Global Biofund |